Korea Institute of Science and Technology

Ctc Bio, Inc.

Cornell University

Ferring B.v.

Min Seop Kim

Won Il Cho

Mun Sek Kim

In Wook Nah

Bong-Sang Lee

Hong Ryeol Jeon

Su-Jun Park

Do-Woo Kwon

Van Dung Do

Myeongcheol Kil

Jiyeong Han

Seung Hun Lee

In Hwan Oh

Lynden A Archer

Sun Min Park

Snehashis Choudhury

Ji Hyun Ryu

Zhengyuan Tu

Bong Sang Lee

An artificial solid electrolyte interphase (ASEI) of an anode for a secondary battery includes a first film composed of amino-functionalized, reduced graphene oxide (rGO) that is amino-functionalized by binding with polyethyleneimine present in an amount of from 1 to 50% by weight, based on total weight of the amino-functionalized, reduced graphene oxide (rGO) and that is disposed in contact with an anode material to protect the anode material; and a second film comprised of amino-functionalized, multi-walled carbon nanotubes that is amino-functionalized by binding with polyethyleneimine and that is stacked on the first film. An anode of a secondary battery including the ASEI enables rapid diffusion and stable deposition of lithium to inhibit the formation of dendrites. In a secondary battery including the anode, the ASEI prevents side reactions between a lithium metal anode and the electrolyte, achieving good electrochemical stability and high Coulombic efficiency.

Artificial solid electrolyte interphase of a metallic anode for a secondary battery including amino-functionalized carbon structures to protect the anode material, a method for producing the anode and a lithium metal secondary battery including the anode produced by the method

The present disclosure relates to an aqueous binder for a lithium-sulfur secondary battery, a method for preparing the same, and a lithium-sulfur secondary battery including the same. More particularly, it is possible to obtain an aqueous binder (PEI/PVP/CA, PPC) by adding citric acid to a mixed solution of polyethylene imine with polyvinyl pyrrolidone, and to apply the aqueous binder to a lithium-sulfur secondary battery having high discharge capacity, Coulombic efficiency and stable life characteristics through the improvement of adhesion capability even at a sulfur cathode with high energy density, inhibition of a shuttle reaction and inhibition of metal current collector corrosion.

Aqueous binder for lithium-sulfur secondary battery, preparation method thereof and lithium-sulfur secondary battery comprising the same

Disclosed is an electrolyte for a lithium metal secondary battery and a lithium metal secondary battery including the same. An electrolyte system is intended to maintain the energy density of a secondary battery based on a lithium metal negative electrode and to extend the life of a battery. Particularly, an electrolyte for a lithium metal battery which forms a stable SEI film capable of inhibiting formation and extension of lithium dendrite so that the negative electrode of a lithium metal battery having a high possibility of battery ignition may be stabilized and an internal short-circuit may be prevented, and a lithium metal secondary battery including the same is provided.

Electrolyte system for lithium metal secondary battery and lithium metal secondary battery including the same

Provided is a lithium metal anode comprising a Langmuir-Blodgett films as an artificial solid electrolyte interface layer, a lithium metal battery comprising the same, and a preparation method thereof. Various ultra-thin film layers made of carbon and ceramic are formed on the surface of the LiM to serve as a stable artificial SEI layer and suppress formation and perforation of lithium dendrite and side reactions.

Lithium metal anode comprising Langmuir-Blodgett films as an artificial solid electrolyte interface layer, lithium metal battery comprising the same, and preparation method thereof

The present invention relates to a pharmaceutical preparation for oral administration comprising, as an active ingredient, clomipramine or a pharmaceutically acceptable salt thereof; and a cation exchange resin and an anion polymer as a taste masking agent, wherein the pharmaceutical preparation can be orally administered even while comprising a pharmaceutically effective amount of clomipramine because the unique tastes of clomipramine, particularly, all of the bitter taste, spicy taste and burning taste are effectively masked, and thus the convenience of drug intake and portability is improved, and a method for manufacturing thereof.

Pharmaceutical preparation for masked taste oral administration, containing clomipramine

The present invention relates to a pharmaceutical preparation comprising entecavir as an active ingredient, wherein an antioxidizing agent is added to enhance stability of entecavir, and a method for preparing the same. According to the present invention, the invention has an effect that entecavir can be stably maintained in a pharmaceutical preparation containing a certain amount or more of moisture by adding the antioxidizing agent, thereby a pharmaceutical preparation can be provided as a formulation containing a certain amount or more of moisture, for example, an orally disintegrating film formulation.

Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor

Growing community of inventors

Seoul, South Korea

Min Seop Kim